Header Logo

Connection

Mark Pollack to Antibodies, Bacterial

This is a "connection" page, showing publications Mark Pollack has written about Antibodies, Bacterial.
Connection Strength

0.663
  1. Dual effects of LPS antibodies on cellular uptake of LPS and LPS-induced proinflammatory functions. J Immunol. 1997 Oct 01; 159(7):3519-30.
    View in: PubMed
    Score: 0.152
  2. Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06. Infect Immun. 1994 Apr; 62(4):1137-43.
    View in: PubMed
    Score: 0.119
  3. Specificity and function of monoclonal antibodies reactive with discrete structural elements of bacterial lipopolysaccharide. Adv Exp Med Biol. 1990; 256:331-40.
    View in: PubMed
    Score: 0.089
  4. Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans. J Infect Dis. 1983 Jun; 147(6):1090-8.
    View in: PubMed
    Score: 0.056
  5. Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections. Am J Med. 1983 Jun; 74(6):980-7.
    View in: PubMed
    Score: 0.056
  6. Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay. J Clin Microbiol. 1977 Jul; 6(1):58-61.
    View in: PubMed
    Score: 0.037
  7. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Invest Ophthalmol Vis Sci. 1997 Jun; 38(7):1418-25.
    View in: PubMed
    Score: 0.037
  8. Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection. Infect Immun. 1976 Oct; 14(4):942-7.
    View in: PubMed
    Score: 0.035
  9. Isolation, structure, and immunogenicity of Pseudomonas aeruginosa immunotype 4 high-molecular-weight polysaccharide. Infect Immun. 1989 Feb; 57(2):426-31.
    View in: PubMed
    Score: 0.021
  10. The virulence of Pseudomonas aeruginosa. Rev Infect Dis. 1984 Sep-Oct; 6 Suppl 3:S617-26.
    View in: PubMed
    Score: 0.015
  11. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core. J Clin Invest. 1983 Dec; 72(6):1874-81.
    View in: PubMed
    Score: 0.015
  12. Pseudomonas aeruginosa exotoxin A. N Engl J Med. 1980 Jun 12; 302(24):1360-2.
    View in: PubMed
    Score: 0.011
  13. Cholera in Piura, Peru: a modern urban epidemic. J Infect Dis. 1992 Dec; 166(6):1429-33.
    View in: PubMed
    Score: 0.007
  14. Fluorescence-activated cell sorter analysis of binding by lipopolysaccharide-specific monoclonal antibodies to gram-negative bacteria. J Infect Dis. 1990 Jul; 162(1):148-55.
    View in: PubMed
    Score: 0.006
  15. The outlook for prevention and treatment of infections due to Pseudomonas aeruginosa. Rev Infect Dis. 1984 Sep-Oct; 6 Suppl 3:S769-74.
    View in: PubMed
    Score: 0.004
  16. Immunochemical characterization of high-molecular-weight polysaccharide from Fisher immunotype 3 Pseudomonas aeruginosa. Infect Immun. 1984 Aug; 45(2):309-13.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.